| Significant risk of graft-versus-host disease with exposure to checkpoint inhibitors before and after allogeneic transplantation A Ijaz, AY Khan, SU Malik, W Faridi, MA Fraz, M Usman, MJ Tariq, S Durer, ... Biology of Blood and Marrow Transplantation 25 (1), 94-99, 2019 | 156 | 2019 |
| Concomitant use of blinatumomab and donor lymphocyte infusion for mixed-phenotype acute leukemia: a case report with literature review S Durer, C Durer, M Shafqat, IY Comba, S Malik, W Faridi, S Aslam, A Ijaz, ... Immunotherapy 11 (5), 373-378, 2019 | 23 | 2019 |
| Special considerations for the treatment of multiple myeloma according to advanced age, comorbidities, frailty and organ dysfunction MA Fraz, FH Warraich, SU Warraich, MJ Tariq, Z Warraich, AY Khan, ... Critical reviews in oncology/hematology 137, 18-26, 2019 | 18 | 2019 |
| Treating diffuse large B cell lymphoma in the very old or frail patients A Kumar, MA Fraz, M Usman, SU Malik, A Ijaz, C Durer, S Durer, MJ Tariq, ... Current treatment options in oncology 19, 1-10, 2018 | 10 | 2018 |
| Concomitant use of blinatumomab and donor lymphocyte infusion for post-transplant relapsed CD19 positive acute lymphoblastic leukemia: systematic review C Durer, S Durer, M Shafqat, Z Shah, M Sadiq, MA Fraz, MQ Ahmad, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 8 | 2018 |
| Clinical response and tolerability of selinexor in acute myeloid leukemia and other hematologic malignancies-a systematic review MJ Tariq, M Yasir, A Khalid, SN Amin, S Samuel, MJ Khalil, S Aslam, ... Blood 132, 5231, 2018 | 5 | 2018 |
| 302. Role of inflammatory markers in diagnosing diabetic foot infection: a meta-analysis A Majeed, A Mushtaq, A Iftikhar, U Zahid, F Sagar, M Usman, M Fraz, ... Open Forum Infectious Diseases 5 (suppl_1), S122-S123, 2018 | 4 | 2018 |
| The use of checkpoint inhibitors before and after allogeneic stem cell transplantion: a double-edged sword AY Khan, A Ijaz, M Usman, MJ Tariq, MA Fraz, MJ Khalil, C Durer, S Durer, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 2 | 2018 |
| Extrapyramidal Symptoms with Administration of Lenalidomide Maintenance Therapy for Multiple Myeloma FNU Sagar, SU Malik, S Soontornprueksa, A Ijaz, M Usman, AY Khan, ... Cureus 10 (9), 2018 | 2 | 2018 |
| Pattern of Stress among Medical Students of Faisalabad Medical University, Faisalabad and Non-Medical Students of University of Agriculture, Faisalabad MU Jahngir, HSH Imam, MQ Ahmad, M Jahangir, MA Fraz, MS Ghaffar Epidemiology (Sunnyvale) 8 (349), 2161-1165.1000349, 2018 | 2 | 2018 |
| MON-LB009 renin angiotensin aldosterone system inactivation in postural orthostatic tachycardia syndrome V Kumar, S Usmani, S Alam, M Fraz, D Patel, P Goparaju, T Burphy, ... Journal of the Endocrine Society 3 (Supplement_1), MON-LB009, 2019 | 1 | 2019 |
| Efficacy and tolerability of daratumumab in heavily pretreated al amyloidosis: a systematic review MA Rahman, AY Khan, A Ijaz, MJ Tariq, M Usman, MJ Khalil, MA Fraz, ... Blood 132, 2025, 2018 | 1 | 2018 |
| Efficacy and Safety of Histone Deacetylase Inhibitors in Multiple Myeloma-a Systematic Review of Early Phase Clinical Trials S Samuel, MJ Tariq, M Usman, A Khalid, MA Fraz, A Ijaz, F Jamil, M Yasir, ... Blood 132, 5629, 2018 | 1 | 2018 |
| Outcomes of T-Cell Depleted Haploidentical Peripheral Blood Stem Cell Transplantation for Adult Acute Leukemia: A Meta-Analysis S Durer, C Durer, E Katsanis, IY Comba, F Jamil, S Aslam, Z Shah, ... Blood 132, 5779, 2018 | | 2018 |
| Efficacy of Lenalidomide Based Three Drug Versus Two Drug Regimen for Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Trials M Usman, W Faridi, MA Fraz, MJ Tariq, SU Malik, F Sagar, A Ijaz, ... Blood 132, 3239, 2018 | | 2018 |
| Sequencing Therapy for Elderly Chronic Lymphocytic Leukemia Patients in the Era of Novel Therapies: An Overview of Randomized Clinical Trials MQ Ahmad, CS Sohail, M Yasir, MJ Tariq, A Akbar, MJ Khalil, M Usman, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | | 2018 |
| Myelofibrosis Drug Development through the Decade: Novel JAK Inhibitors AY Khan, MJ Tariq, M Usman, A Ijaz, A Rafae, MN Malik, HM Fazeel, ... Blood 132, 5477, 2018 | | 2018 |
| Efficacy, Toxicity and Targets for Adoptive Cellular Therapy in Multiple Myeloma: A Systematic Review M Usman, MJ Tariq, A Ijaz, MA Fraz, AY Khan, NCNC Parr, MJ Khalil, ... Blood 132, 5649, 2018 | | 2018 |
| Antibodies in Development for Multiple Myeloma: A Systematic Review MA Fraz, MJ Tariq, M Usman, NCNC Parr, A Ijaz, MQ Ahmad, M Yasir, ... Blood 132, 5656, 2018 | | 2018 |
| Safety and Efficacy of Venetoclax in Relapsed Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis C Durer, S Durer, A Ijaz, A Kamal, MA Zar, A Rafae, MN Malik, AY Khan, ... Blood 132, 5625, 2018 | | 2018 |
